Compounds > zm 241385
Page last updated: 2024-09-05

zm 241385 and 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine

zm 241385 has been researched along with 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine in 1 studies

Compound Research Comparison

Studies
(zm 241385)		Trials
(zm 241385)		Recent Studies (post-2010)
(zm 241385)		Studies
(8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)		Trials
(8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)		Recent Studies (post-2010) (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine)
40131241603

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahern, DG; Jacobson, KA; Ji, X; Kim, YC; Linden, J1

Other Studies

1 other study(ies) available for zm 241385 and 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine

ArticleYear
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
    Biochemical pharmacology, 2001, Mar-15, Volume: 61, Issue:6

    Topics: Acetamides; Cells, Cultured; Humans; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Radiopharmaceuticals; Receptor, Adenosine A2B; Tritium

2001